Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Defining Successful Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (HCT)

Mayada Salman Abu Shanap, MD, Sarah Cooley, MD, Xianghua Luo, PhD, Cao Qing, Julie Curtsinger, PhD, Rachel Bergerson, PhD, Nelli Bejanyan, Heather Stefanski, MD PhD, Claudio Brunstein, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, John E Wagner, MD, Michael R. Verneris, MD

Blood (2015) 126 (23): 1934.

https://doi.org/10.1182/blood.V126.23.1934.1934

Published: 2015

Journal Articles

CMV Reactivation is Associated with Reduced Relapse Risk, Better Disease-Free Survival and Expansion of Adaptive NK Cells after Reduced Intensity Hematopoietic Cell Transplantation

Frank Cichocki, PhD, Zachary B. Davis, PhD, Todd E. DeFor, MS, Sarah A. Cooley, MD MS, Yenan T. Bryceson, PhD, Don J. Diamond, PhD, Bruce R. Blazar, MD, Claudio Brunstein, MD, John E. Wagner, MD, Michael R. Verneris, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD

Blood (2014) 124 (21): 668.

https://doi.org/10.1182/blood.V124.21.668.668

Published: 2014

Journal Articles

StemRegenin-1 (SR1) Expansion Culture Abrogates the Engraftment Barrier Associated with Umbilical Cord Blood Transplantation (UCBT)

John E Wagner, MD, Claudio Brunstein, MD, David McKenna, MD, Darin Sumstad, MT(ASCP), Suzanne Maahs, Mary Laughlin, MD, Michael S. Perry, DVM,PhD, Anthony E. Boitano, PhD, Michael P. Cooke, PhD, Conrad C. Bleul, MD

Blood (2014) 124 (21): 728.

https://doi.org/10.1182/blood.V124.21.728.728

Published: 2014

Journal Articles

Clonal Expansion of Adaptive NK Cells and NKG2C + CD57 + KIR-Expressing T Cells from Sibling, but Not Umbilical Cord Blood, Grafts Is Induced By Recipient Latent CMV and Is Associated with Protection Against CMV Reactivation

Zachary B. Davis, PhD, Frank Cichocki, PhD, Martin Felices, PhD, Rose Wangen, Todd E. DeFor, MS, Sarah A. Cooley, MD MS, Yenan T. Bryceson, PhD, Don J. Diamond, PhD, Claudio Brunstein, MD, Bruce R. Blazar, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Amir Horowitz, Lisbeth A Guethlein, Peter Parham, PhD, Michael R. Verneris, MD, Jeffrey S. Miller, MD

Blood (2014) 124 (21): 181.

https://doi.org/10.1182/blood.V124.21.181.181

Published: 2014

Journal Articles

Risk Factors for Acute and Chronic Gvhd after Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Relative Risks with Umbilical Cord Blood (UCB) and Matched Related Donors (MRD)

Aleksandr Lazaryan, MD PhD MPH, Todd E. DeFor, MS, Claudio Brunstein, MD, Margaret L. MacMillan, MD, Nelli Bejanyan, MD, Shernan G. Holtan, MD, Bruce R. Blazar, MD, John E Wagner, MD, Daniel J. Weisdorf, MD, Mukta Arora, MD MS

Blood (2014) 124 (21): 189.

https://doi.org/10.1182/blood.V124.21.189.189

Published: 2014

Journal Articles

Phosphoramide Mustard As a Biomarker Of Cyclophosphamide Exposure In Adults Receiving Reduced Intensity Conditioning Hematopoietic Cell Transplantation

Anthony C. Wiseman, BS, Sanghavi Kinjal, BS, MS, Claudio Brunstein, MD, Erica D. Warlick, MD, Daniel J. Weisdorf, MD, Qing Cao, MS, John Rogosheske, PharmD, Pamala A. Jacobson

Blood (2013) 122 (21): 5461.

https://doi.org/10.1182/blood.V122.21.5461.5461

Published: 2013

Journal Articles

Alternative Donor Transplantation For Adults With Lymphoma: Comparison Of Umbilical Cord Blood Versus 8/8 HLA-Matched Donor (URD) Versus 7/8 URD

Veronika Bachanova, MD, Claudio Brunstein, MD, Linda J. Burns, MD, Tao Wang, PhD, Jeanette Carreras, MPH, Ginna G. Laport, MD, Sonali M. Smith, MD, Silvia Montoto, MD, David G. Maloney, MD, PhD, Wael Saber, MD, MS

Blood (2013) 122 (21): 161.

https://doi.org/10.1182/blood.V122.21.161.161

Published: 2013

Journal Articles

Early NK Cell Proliferation After Umbilical Cord Blood Transplantation Is Associated With Superior Disease-Free Survival Due To Reduced Leukemia Relapse

Rachel Joy Bergerson, PhD, Sarah Cooley, MD, Julie Curtsinger, PhD, Ryan Shanley, Claudio Brunstein, MD, Bruce R Blazar, MD, John E. Wagner, MD, Jeffrey S. Miller, MD, Michael R. Verneris, MD

Blood (2013) 122 (21): 4610.

https://doi.org/10.1182/blood.V122.21.4610.4610

Published: 2013

Journal Articles

Alternative Donor Hematopoietic Transplantation For Patients Older Than 50 Years With AML In First Complete Remission: Unrelated Donor and Umbilical Cord Blood Transplantation Outcomes

Daniel J. Weisdorf, MD, Mary Eapen, MBBS, MS, Annalisa Ruggeri, MD, Mei-Jie Zhang, PhD, Xiaobo Zhong, MS, Claudio Brunstein, MD, Celalettin Ustun, Vanderson Rocha, MD, Eliane Gluckman, MD

Blood (2013) 122 (21): 302.

https://doi.org/10.1182/blood.V122.21.302.302

Published: 2013

Journal Articles

Unrelated Cord Blood Transplantation (UCBT) in Adult and Pediatric Acute Lymphoblastic Leukemia: Impact of Minimal Residual Disease on Relapse and Survival,

Veronika Bachanova, MD, Michael J Burke, MD, Claudio Brunstein, MD, Michael R Verneris, MD, Qing Cao, MS, John E. Wagner, MD, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 4114.

https://doi.org/10.1182/blood.V118.21.4114.4114

Published: 2011

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Overcomes the Adverse Prognostic Impact of Minimal Residual Disease in Acute Myeloid Leukemia

Betul Oran, MD, MS, Timothy Singleton, MD, Pablo A. Ramirez, MD, Ryan Shanley, MS, Claudio Brunstein, MD, Celalettin Ustun, MD, Erica D Warlick, MD, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 2027.

https://doi.org/10.1182/blood.V118.21.2027.2027

Published: 2011

Journal Articles

Elevated Absolute Lymphocyte Counts Following Acute Graft Vs. Host Disease Treatment Is Associated with Therapeutic Responses and Lower Non-Relapse Mortality Following Umbilical Cord Blood Transplant,

Michael R Verneris, MD, Sanyukta Janardan, BS, Michael J Burke, MD, Todd E. Defor, MS, Claudio Brunstein, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, John E. Wagner, MD, Daniel Weisdorf, MD, Margaret L. MacMillan, MD

Blood (2011) 118 (21): 4085.

https://doi.org/10.1182/blood.V118.21.4085.4085

Published: 2011

Journal Articles

The Impact of Bone Marrow Hematogones on Umbilical Cord Blood Transplant Outcomes in Acute Myeloid Leukemia Patients,

Theodore Honebrink, MD, Vanessa J. Dayton, MD, Karen Larsen, MD, Qing Cao, MS, Claudio Brunstein, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD, John E. Wagner, MD, Michael R Verneris, MD

Blood (2011) 118 (21): 4148.

https://doi.org/10.1182/blood.V118.21.4148.4148

Published: 2011

Journal Articles

ABO Mismatch Adversely Affects GvHD In Recipients of HLA Matched Unrelated Marrow or Peripheral Blood but Not Single or Double Umbilical Cord Blood Transplants

Rizwan Romee, MD, Daniel J. Weisdorf, MD, Claudio Brunstein, MD, John E. Wagner, MD, Bruce R. Blazar, MD, Navneet S. Majhail, MD, MS, Gregory M. Vercellotti, MD, Jeffrey S. Miller, MD, Mukta Arora, MD

Blood (2010) 116 (21): 226.

https://doi.org/10.1182/blood.V116.21.226.226

Published: 2010

Journal Articles

Reduced Intensity Versus Myeloablative Conditioning in Adults with Acute Myeloid Leukemia Transplanted with Umbilical Cord Blood

Betul Oran, MD, MS, John E. Wagner, MD, Todd Defor, Daniel J. Weisdorf, MD, Claudio Brunstein, MD

Blood (2010) 116 (21): 3531.

https://doi.org/10.1182/blood.V116.21.3531.3531

Published: 2010

Journal Articles

Impact of Graft Source on Immune Recovery: Comparions Between Unrelated Umbilical Cord Blood (UCB), HLA Matched Sibling (Sib) Donor and Autologous (Auto) Hematopoietic Stem Cells.

Sarah Cooley, MD, John E. Wagner, MD, Claudio Brunstein, MD, Mie Hagiwara, Giordi Orreggio, Julie Curtsinger, PhD, Todd Defor, Xianghua Luo, Bruce R. Blazar, MD, Phillip McGlave, MD, Jeffrey S. Miller, MD, Michael R Verneris, MD

Blood (2010) 116 (21): 3731.

https://doi.org/10.1182/blood.V116.21.3731.3731

Published: 2010

Journal Articles

Donor-Derived Myelodysplastic Syndrome and Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Incidence, Natural History and Treatment Response

Andrew C. Dietz, MD, Scott Jackson, MS, Betsy A. Hirsch, PhD, Claudio Brunstein, MD, John E. Wagner, MD

Blood (2010) 116 (21): 1306.

https://doi.org/10.1182/blood.V116.21.1306.1306

Published: 2010

Journal Articles

Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation

Pablo A. Ramirez, MD, John E. Wagner, MD, Todd Defor, MS, Bruce R. Blazar, MD, Michael Verneris, MD, Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Phillip McGlave, MD, Claudio Brunstein, MD

Blood (2010) 116 (21): 225.

https://doi.org/10.1182/blood.V116.21.225.225

Published: 2010

Journal Articles

Reduced Intensity Conditioning (RIC) Transplantation In Acute Leukemia: The Effect of Source of Unrelated Donor Stem Cells on Outcomes

Claudio Brunstein, MD, Mary Eapen, MBBS, Kwang w Ahn, PhD, Frederick R. Appelbaum, MD, Karen K Ballen, MD, Richard Champlin, Fangyu Kan, MS, Mary J. Laughlin, MD, Robert J Soiffer, MD, Daniel J. Weisdorf, MD, Ann Woolfrey, MD, Mary M. Horowitz, MD, MS, John E. Wagner, MD

Blood (2010) 116 (21): 908.

https://doi.org/10.1182/blood.V116.21.908.908

Published: 2010

Journal Articles

Relapse of Lymphoma After Allogeneic Hematopoietic Cell Transplantation: Management Strategies and Outcome.

Kitsada Wudhikarn, MD, Qing Cao, MS, Claudio Brunstein, MD, Veronika Bachanova, Linda J Burns, MD, Daniel J. Weisdorf, MD

Blood (2010) 116 (21): 4503.

https://doi.org/10.1182/blood.V116.21.4503.4503

Published: 2010

NARROW

Defining Successful Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (HCT)

CMV Reactivation is Associated with Reduced Relapse Risk, Better Disease-Free Survival and Expansion of Adaptive NK Cells after Reduced Intensity Hematopoietic Cell Transplantation

StemRegenin-1 (SR1) Expansion Culture Abrogates the Engraftment Barrier Associated with Umbilical Cord Blood Transplantation (UCBT)

Clonal Expansion of Adaptive NK Cells and NKG2C + CD57 + KIR-Expressing T Cells from Sibling, but Not Umbilical Cord Blood, Grafts Is Induced By Recipient Latent CMV and Is Associated with Protection Against CMV Reactivation

Risk Factors for Acute and Chronic Gvhd after Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Relative Risks with Umbilical Cord Blood (UCB) and Matched Related Donors (MRD)

Phosphoramide Mustard As a Biomarker Of Cyclophosphamide Exposure In Adults Receiving Reduced Intensity Conditioning Hematopoietic Cell Transplantation

Alternative Donor Transplantation For Adults With Lymphoma: Comparison Of Umbilical Cord Blood Versus 8/8 HLA-Matched Donor (URD) Versus 7/8 URD

Early NK Cell Proliferation After Umbilical Cord Blood Transplantation Is Associated With Superior Disease-Free Survival Due To Reduced Leukemia Relapse

Alternative Donor Hematopoietic Transplantation For Patients Older Than 50 Years With AML In First Complete Remission: Unrelated Donor and Umbilical Cord Blood Transplantation Outcomes

Unrelated Cord Blood Transplantation (UCBT) in Adult and Pediatric Acute Lymphoblastic Leukemia: Impact of Minimal Residual Disease on Relapse and Survival,

Allogeneic Hematopoietic Stem Cell Transplantation Overcomes the Adverse Prognostic Impact of Minimal Residual Disease in Acute Myeloid Leukemia

Elevated Absolute Lymphocyte Counts Following Acute Graft Vs. Host Disease Treatment Is Associated with Therapeutic Responses and Lower Non-Relapse Mortality Following Umbilical Cord Blood Transplant,

The Impact of Bone Marrow Hematogones on Umbilical Cord Blood Transplant Outcomes in Acute Myeloid Leukemia Patients,

ABO Mismatch Adversely Affects GvHD In Recipients of HLA Matched Unrelated Marrow or Peripheral Blood but Not Single or Double Umbilical Cord Blood Transplants

Reduced Intensity Versus Myeloablative Conditioning in Adults with Acute Myeloid Leukemia Transplanted with Umbilical Cord Blood

Impact of Graft Source on Immune Recovery: Comparions Between Unrelated Umbilical Cord Blood (UCB), HLA Matched Sibling (Sib) Donor and Autologous (Auto) Hematopoietic Stem Cells.

Donor-Derived Myelodysplastic Syndrome and Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Incidence, Natural History and Treatment Response

Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation

Reduced Intensity Conditioning (RIC) Transplantation In Acute Leukemia: The Effect of Source of Unrelated Donor Stem Cells on Outcomes

Relapse of Lymphoma After Allogeneic Hematopoietic Cell Transplantation: Management Strategies and Outcome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only